Indeed, OMP-A2G1 alone inhibited tumor growth to a greater extent than docetaxel alone, which inspires the thought that specific Notch1 inhibition may not be sufficient to potentiate taxanes’ therapeutic effect in this cancer [492]. This evidence concerns the gene NOTCH1 and neoplasm.